• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Life Science Market
    Life Science News
    Life Science Stocks
    • Life Science Market
    • Life Science News
    • Life Science Stocks

    Promega Replaces Production Site with New Shanghai Facility

    Charlotte McLeod
    Nov. 19, 2012 12:43PM PST
    Life Science Investing

    Asian Scientist Magazine reported that Promega Corp., a life sciences manufacturer, replaced a molecular biology reagent production site with a new facility in Shanghai, China last week. The company bought the new building in June, and 40 scientists, technicians and administrators will start work there over the next several weeks.

    Asian Scientist Magazine reported that Promega Corp., a life sciences manufacturer, replaced a molecular biology reagent production site with a new facility in Shanghai, China last week. The company bought the new building in June, and 40 scientists, technicians and administrators will start work there over the next several weeks.

    As quoted in the market news:

    The new site … provides additional research, development, and cGMP manufacturing capabilities for molecular diagnostics products for the Chinese market.

    The new facility, called the Shanghai Promega Life Science Center, is one of five Promega manufacturing sites worldwide. Together these facilities manufacture biological and chemical reagents and instruments used in both life science research and molecular diagnostics. Promega products are manufactured under certified quality systems that meet the requirement of ISO 9001 or ISO 13485, depending on product intended use.

    Click here to read the full Asian Scientist Magazine report.

    chinalife-science-investingmolecular-diagnostics
    The Conversation (0)

    Go Deeper

    AI Powered
    Microscopic view of stem cells.

    Stem Cell Stocks: 10 Biggest NASDAQ Companies in 2025

    A floating DNA double helix above a hand with a blue background.

    Top 4 NASDAQ Genetics Stocks (Updated January 2026)

    Latest News

    Seegnal Expands Deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a Leading Israeli Public Medical Center and Global Referral Center

    Lobe Sciences Reports First Quarter 2026 Results and Highlights

    More News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Life Science Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES